Press Releases about Mirati Therapeutics![]() ![]()
Bristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Race
October 17, 2023
Via PressReach
![]() From Brodsky & Smith LLC
Via GlobeNewswire
![]()
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
October 10, 2023
Via PressReach
![]() ![]() ![]() ![]() ![]()
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
November 15, 2022
Topics
Death
Exposures
Death
![]() ![]()
Artificial Intelligence Being Used to Accurately Predict Synergistic Cancer Drug Combinations
December 10, 2021
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Investigation Announced for Long-Term Investors in Mirati Therapeutics, Inc. (NASDAQ:MRTX)
December 07, 2021
Via SBWire
Topics
Regulatory Compliance
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Mirati Therapeutics (NQ: MRTX )Press Releases about Mirati Therapeutics
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|